Previous 10 | Next 10 |
2024-05-01 17:07:44 ET Summary Amgen Inc. shares have dropped some 20% since reaching an all-time high in February due to a below-consensus outlook and patent concerns. The company's four pillars of growth are General Medicine, Oncology, Inflammatory Diseases, and Rare Diseases. ...
2024-05-01 14:41:05 ET Summary Eli Lilly and Company's revenue for the first quarter of 2024 fell short of analysts' expectations, but the company exceeded forecasts on the bottom line. Sales of the company's obesity and diabetes drugs, particularly Mounjaro and Zepbound, saw sign...
2024-04-30 12:18:17 ET More on AstraZeneca, GSK, etc. AstraZeneca: A Triple Shot Of Income, Growth, And Value Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy AstraZeneca: Strong In A Weak Market GSK Q1 2024 Earnings Preview Ast...
2024-04-30 07:31:21 ET More on Eli Lilly Eli Lilly And The Alzheimer's Dilemma (Rating Upgrade) Wall Street Lunch: Lilly In Limelight Eli Lilly: Three Threats To Its Huge Rally Eli Lilly Non-GAAP EPS of $2.58 beats by $0.09, revenue of $8.77B misses by $160M ...
2024-04-28 12:35:00 ET Summary Artisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated clients globally. We outperformed our benchmark by about 225bps this quarter. Our top two contribut...
2024-04-28 10:34:47 ET More on Eli Lilly, Novo Nordisk, etc. Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy Novo Nordisk Remains The Better Buy After A Moderate Pullback Eli Lilly And The Alzheimer's Dilemma (Rating Upgrade) Novo Nord...
2024-04-27 11:10:00 ET Nvidia has been an amazing stock to own over the past few years, generating incredible returns for investors. But the risk is that expectations may be too high for the stock, especially with respect to artificial intelligence (AI). And that means the stock could b...
2024-04-26 12:15:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy outperfor...
2024-04-26 12:00:34 ET Summary Novo Nordisk's weight loss drug, Wegovy, has received FDA approval for reducing the risk of major cardiovascular adverse events. Wegovy demonstrated a 20% reduction in the risk of major cardiovascular adverse events and a 19% reduction in the risk of...
2024-04-26 11:33:56 ET Summary Shares of AstraZeneca reached new all-time highs this week despite difficult market conditions in the last two months. The revenue and EPS beats were driven by the strong performance of all key growth products. Recent pipeline wins from Imfinzi, ...
News, Short Squeeze, Breakout and More Instantly...
Novo Nordisk A/S Company Name:
NVO Stock Symbol:
NYSE Market:
2024-06-02 09:30:00 ET The pharmaceutical industry isn't the first place investors turn to when looking for high-growth stocks. However, some companies in the field look so promising that they could deliver well-above-average returns through the end of the decade. There are several cand...
2024-06-02 08:25:00 ET Over the last few years, some of the best-performing stocks in the broader healthcare space have been pharmaceutical businesses . A big reason for this is the rise in popularity of weight loss medications. Ozempic and Wegovy are two of the most mainstream trea...
2024-06-01 10:25:00 ET Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are the two most valuable healthcare companies in the world. Combined, they're worth nearly $1.4 trillion. And it's conceivable that their individual valuations could top $1 trillion in the future. How...